Your browser doesn't support javascript.
loading
The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates.
Buhigas, Claudia; Warren, Anne Y; Leung, Wing-Kit; Whitaker, Hayley C; Luxton, Hayley J; Hawkins, Steve; Kay, Jonathan; Butler, Adam; Xu, Yaobo; Woodcock, Dan J; Merson, Sue; Frame, Fiona M; Sahli, Atef; Abascal, Federico; Martincorena, Iñigo; Bova, G Steven; Foster, Christopher S; Campbell, Peter; Maitland, Norman J; Neal, David E; Massie, Charlie E; Lynch, Andy G; Eeles, Rosalind A; Cooper, Colin S; Wedge, David C; Brewer, Daniel S.
  • Buhigas C; Norwich Medical School, University of East Anglia, Norwich, Norfolk, NR4 7TJ, UK.
  • Warren AY; Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK.
  • Leung WK; Cancer Research UK Cambridge Institute, Cambridge, CB2 0RE, UK.
  • Whitaker HC; Cancer Research UK Cambridge Institute, Cambridge, CB2 0RE, UK.
  • Luxton HJ; Molecular Diagnostics and Therapeutics Group, Division of Surgery and Interventional Sciences University College London, London, W1W 7TS, UK.
  • Hawkins S; Cancer Research UK Cambridge Institute, Cambridge, CB2 0RE, UK.
  • Kay J; Molecular Diagnostics and Therapeutics Group, Division of Surgery and Interventional Sciences University College London, London, W1W 7TS, UK.
  • Butler A; Cancer Research UK Cambridge Institute, Cambridge, CB2 0RE, UK.
  • Xu Y; Cancer Research UK Cambridge Institute, Cambridge, CB2 0RE, UK.
  • Woodcock DJ; Molecular Diagnostics and Therapeutics Group, Division of Surgery and Interventional Sciences University College London, London, W1W 7TS, UK.
  • Merson S; Cancer, Ageing and Somatic Mutation, Wellcome Trust Sanger Institute, Hinxton, CB10 1RQ, UK.
  • Frame FM; Cancer, Ageing and Somatic Mutation, Wellcome Trust Sanger Institute, Hinxton, CB10 1RQ, UK.
  • Sahli A; Oxford Big Data Institute, University of Oxford, Old Road Campus, Oxford, OX3 7LF, UK.
  • Abascal F; The Institute of Cancer Research, London, SW7 3RP, UK.
  • Martincorena I; Oxford Big Data Institute, University of Oxford, Old Road Campus, Oxford, OX3 7LF, UK.
  • Bova GS; Cancer, Ageing and Somatic Mutation, Wellcome Trust Sanger Institute, Hinxton, CB10 1RQ, UK.
  • Campbell P; Cancer, Ageing and Somatic Mutation, Wellcome Trust Sanger Institute, Hinxton, CB10 1RQ, UK.
  • Maitland NJ; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, 33014, Tampere, FI, Finland.
  • Neal DE; HCA Laboratories, London, WC1E 6JA, UK.
  • Massie CE; Cancer, Ageing and Somatic Mutation, Wellcome Trust Sanger Institute, Hinxton, CB10 1RQ, UK.
  • Lynch AG; Cancer Research Unit, Department of Biology, University of York, Heslington, YO10 5DD, North Yorkshire, UK.
  • Eeles RA; Cancer Research UK Cambridge Institute, Cambridge, CB2 0RE, UK.
  • Cooper CS; Cancer Research UK Cambridge Institute, Cambridge, CB2 0RE, UK.
  • Wedge DC; Department of Oncology, University of Cambridge, Cambridge, CB2 0XZ, UK.
  • Brewer DS; Cancer Research UK Cambridge Institute, Cambridge, CB2 0RE, UK.
Mol Cancer ; 21(1): 183, 2022 09 22.
Article en En | MEDLINE | ID: mdl-36131292
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hiperplasia Prostática / Neoplasias de la Próstata Tipo de estudio: Screening_studies Límite: Humans / Male Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Hiperplasia Prostática / Neoplasias de la Próstata Tipo de estudio: Screening_studies Límite: Humans / Male Idioma: En Año: 2022 Tipo del documento: Article